ANDREW YEE to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications ANDREW YEE has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.048
-
Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. Cancer Cell. 2022 11 14; 40(11):1358-1373.e8.
Score: 0.048